Digestive System
Conditions
Interventions
Albendazole drug
Sponsors
Mesgenaw Tefesa
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All school children whose ages ranged from 7-14 years old attending and who had microscopically confirmed A. lumbricoid mono-infection without history of anti-helminthic drugs in take within the last 6 months before study period and able to to provide required stool samples at the baseline, after 2- 3 weeks and 3 months of baseline albendazole treatment were included in the study
Exclusion criteria
Exclusion criteria: School-age children unable to bring parents/legal guardian to the school, who have a history of known major systemic or chronic illnesses, malnutrition, and GIT diseases, who take anti-in?ammatory drugs/ antibiotics during the study period based on vital signs and prior clinical history, who have been vomiting within 4 hours after drug administration, experienced diarrhea , severe allergic reaction to albendazole, Infected with other than intestinal parasite than A.lumbricoide were excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cure rate or CR .CR means the proportion of individual hosts positive for parasites who become parasitologically negative after treatment or at 14-21 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Egg reduction rate or ERR. Arithmetic mean of Feacal Egg Reduction Rate OR ERR. ERR is the arithmetic mean egg count at baseline of the treatment group minus mean egg count at the end of treatment period divided by the mean egg count at the baseline and express it in percent.;Magnitude of reinfection . The proportion childern who was cured at 14-21 days of treatment divided by the number of re-infected after the three months of albednazole treatments | — |
Countries
Ethiopia
Contacts
Public ContactTegegne;Ababaw Eshetu;Setegn
Lectuer at University of Gondar;Lectuer at university of Gondar
Outcome results
None listed